Clinical Trial Update: Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety and immunogenicity after one or two doses of Novartis Meningococcal ACWY Conjugate Vaccine in healthy infants an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Novartis Meningococcal ACWY Conjugate Vaccine (Meningococcal ACWY conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2013-11-07